Previous Close | 0.5300 |
Open | 0.5400 |
Bid | 0.5002 x 1200 |
Ask | 0.5300 x 1000 |
Day's Range | 0.5001 - 0.5450 |
52 Week Range | 0.4800 - 1.4000 |
Volume | |
Avg. Volume | 216,111 |
Market Cap | 24.965M |
Beta (5Y Monthly) | -1.23 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.2360 |
Earnings Date | Feb 14, 2022 - Feb 18, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
AUSTIN, Texas, May 12, 2022--Astrotech Corporation reported its financial results for the third quarter of fiscal year 2022, which ended March 31, 2022.
AUSTIN, Texas, February 11, 2022--Astrotech Corporation (Nasdaq: ASTC) (the "Company" or "Astrotech") reported its financial results for the second quarter of fiscal year 2022, which ended December 31, 2021.
AUSTIN, Texas, February 02, 2022--Astrotech Corporation (Nasdaq: ASTC) has hired Dr. Karim Sirgi, MD, MBA and FCAP as the Chief Science Officer of subsidiary BreathTech Corporation in preparation of human trials with Cleveland Clinic for its BreathTest-1000™ to help in the battle against COVID-19 and its variants.